| actg019 {hdbayes} | R Documentation |
AIDS Clinical Trial ACTG019
Description
A data set from the AIDS clinical trial ACTG019 (https://clinicaltrials.gov/ct2/show/NCT00000736) comparing zidovudine (AZT) with a placebo in adults with asymptomatic HIV infection. The study results were described in Volberding et al. (1990) doi:10.1056/NEJM199004053221401.
Usage
actg019
Format
A data frame with 822 rows and 5 variables:
- outcome
outcome variable with 1 indicating death, development of AIDS or AIDS-related complex (ARC) and 0 otherwise
- age
patient age in years
- treatment
treatment indicator, 0 = placebo, 1 = AZT
- race
race indicator, 0 = non-white, 1 = white
- cd4
CD4 cell count
References
Volberding, P. A., Lagakos, S. W., Koch, M. A., Pettinelli, C., Myers, M. W., Booth, D. K., Balfour, H. H., Reichman, R. C., Bartlett, J. A., Hirsch, M. S., Murphy, R. L., Hardy, W. D., Soeiro, R., Fischl, M. A., Bartlett, J. G., Merigan, T. C., Hyslop, N. E., Richman, D. D., Valentine, F. T., Corey, L., and the AIDS Clinical Trials Group of the National Institute of Allergy and Infectious Diseases (1990). Zidovudine in asymptomatic human immunodeficiency virus infection. New England Journal of Medicine, 322(14), 941–949.
Chen, M.-H., Ibrahim, J. G., and Yiannoutsos, C. (1999). Prior elicitation, Variable Selection and Bayesian computation for Logistic Regression Models. Journal of the Royal Statistical Society Series B: Statistical Methodology, 61(1), 223–242.